Paracetamol, also named acetaminophen, is an active ingredient in hundreds of over-the-counter (OTC) and prescription medicines. It relieves pain and fever. And, it is also combined with other active ingredients in medicines that treat allergy, cough, colds, flu, and sleeplessness.
In the world the production of paracetamol is highly concentrated in China and India, the two countries occupy about 83.86% of the global production (China 59.02% and India 24.84%) in 2017, and their market share has been increasing in recent years.

The global PAP and Paracetamol market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on PAP and Paracetamol volume and value at global level, regional level and company level. From a global perspective, this report represents overall PAP and Paracetamol market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of PAP and Paracetamol in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their PAP and Paracetamol manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Mallinckrodt
Anqiu Lu'an
Granules India
Zhejiang Kangle
Farmson
Hebei Jiheng
Novacyl
Anhui BBCA Likang
Anhui Fubore
SKPL
Atabay
Huzhou Konch
Changshu Huagang
Anhui Topsun
Sino Chemical

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Powder
Granules

Segment by Application
Tablet Drug
Granules Drug
Oral Solution
Others